ABCB1 and lung cancer: Some studies suggest that disorders of glycoprotein metabolism may be useful as prognostic indicators in patients with lung cancer, such Glycoprotein nonmetastatic melanoma B (GPNMB) [61] and P-glycoprotein [62].